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Introduction
 
The use of implantable cardioverter-defibrillators (ICDs) is 
important for preventing sudden cardiac arrest in patients at 
high risk of fatal ventricular arrhythmias.1) In the past decades, 
cardiologists paid attention primarily to medical problems and 
prolongation of the life expectancy of patients with heart failure. 
Recently, the quality of life as well as survival of such patients 
has been emphasized. Therefore, the demand for subpectoral 
implantation of cardiac implantable electronic devices (CIEDs) is 
increasing in young female patients concerned about their body 
image. We report a case of combined subpectoral implantation 
of ICD and augmentation mammoplasty via the axillary approach 
in a young female patient with dilated cardiomyopathy and small 
breasts.
Case 
A 20-year-old female patient presented to the emergency 
department because of dyspnea and chest discomfort. Chest 
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Fig. 1. M-mode of the left ventricle. (A) Left ventricular end-diastolic 
diameter: 66 mm, (B) left ventricular end-systolic diameter: 57 mm. 
Ejection fraction by M-mode: 20%. 
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radiography showed pulmonary edema and bilateral pleural 
effusion. Transthoracic echocardiogram revealed an enlarged 
left ventricular dimension and severe global hypokinesia of the 
left ventricle (ejection fraction, 20%; Fig. 1). Cardiac magnetic 
resonance images showed severely decreased left ventricular 
function and ill-defined delayed enhancement in the septum, 
both compatible with dilated cardiomyopathy. After 9 months of 
optimal medical treatment including perindopril, furosemide and 
spironolactone, cardiac function had not improved. A beta-blocker 
was not taken due to hypotension after administration of carvedilol. 
The patient still complained of dyspnea on exertion of New York 
Heart Association functional class II. Non-sustained monomorphic 
ventricular tachycardia was detected on 24 h electrocardiogram 
monitoring (Fig. 2). QRS duration during sinus rhythm was 98 ms 
on electrocardiogram. ICD implantation was indicated for primary 
prevention of sudden cardiac arrest. We proposed two options for 
ICD implantation: subcutaneous or subpectoral implantation via 
the axillary incision. The patient preferred the latter option, and 
also requested augmentation mammoplasty for her small breasts. 
After consulting the plastic surgeon, we performed a combined 
subpectoral ICD implantation and augmentation mammoplasty 
procedure via the axillary incision.
Before augmentation mammoplasty, the volumes of right 
and left breasts were 46 and 56 mL, respectively, as measured 
anthropometrically. Under general anesthesia, skin incisions were 
performed on both axillary creases, and the plane between the 
pectoralis major muscle and the rib cage were dissected under 
endoscopic guidance. Two 185 g form-stable gel breast implants 
(Natrelle; Allergan, Irvine, CA, USA) were implanted into the 
subpectoral plane of both breasts. The position and shape of the 
breast implants were inspected in the sitting position. Because 
the patient’s blood pressure decreased in the sitting position, 
norepinephrine was infused intravenously to maintain mean 
arterial blood pressure above 80 mmHg. After bilateral breast 
augmentation by the plastic surgery team, the left axillary vein was 
punctured via the Seldinger technique. A defibrillating ventricular 
lead (Durata 7120Q-58cm; Screw type, St. Jude Medical, Valley 
View Court Sylmar, CA, USA) was inserted into the right ventricle 
via the 9 Fr guiding sheath and was stably anchored at the right 
ventricular apex. An atrial lead (Tendril STS 2088TC-52 cm; Screw 
type, St Jude Medical) was inserted and fixed into the right atrial 
appendage. The ventricular and atrial leads were connected to the 
ICD generator (Ellipse DR, St Jude Medical). The ICD generator was 
implanted into the subpectoral plane immediately above the left 
breast implant. Combined subpectoral ICD implantation via the 
left axillary approach (Fig. 3) and augmentation mammoplasty 
were successfully performed without complications (Fig. 4). After 
augmentation mammoplasty, volumes of the right and left breasts 
were 163 and 169 mL, respectively (Fig. 5). The patient was satisfied 
with her body image after the operation. She did not develop 
ventricular arrhythmias during her 9-month follow-up.
Discussion 
We present herein a successful case of combined subpectoral 
ICD implantation and augmentation mammoplasty via axillary 
incisions in a young female patient who was dissatisfied with her 
body image. 
CIEDs have shown to improve survival and symptoms of patients 
with heart disease, and their use has been increasing.1-3) The use 
of ICD implantation in young patients due to congenital heart 
disease, cardiomyopathy, and genetic disorders, such as a long QT 
Fig. 2. Non-sustained monomorphic ventricular tachycardia detected by 
24 h electrocardiogram monitoring.
Fig. 3. Placement and fixation of the implantable cardioverter-defibrillator 
leads through the axillary incision in the surgical field.
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syndrome, has also increased.4) Currently, quality of life as well as 
survival is important. As the number of young patients who require 
CIED has increased, physicians should be concerned regarding 
not only patients’ medical problems but also esthetic aspects and 
psychological fitness. In particular, young or female patients are 
more concerned about their body image and psychosocial distress 
associated with shock or sudden death rather than older or male 
patients.5)6) Despite the reduction in the size of CIEDs in the last few 
decades, routine subcutaneous device implantation in the pectoral 
area still results in a visible scar and protrusion. Furthermore, 
protrusion at the anterior chest causes awareness of the device and 
discomfort with daily activities when using purse straps, bra straps, 
or seat belts. Therefore, the demand for CIED implantation other 
than subcutaneously has increased. Recently, in the United States, 
the application of subpectoral CIED implantation has increased in 
young female patients having cosmetic concerns.7)8)
Although there are several methods for cosmetic CIED 
implantation, no nomenclature for these methods has been 
suggested. We suggest a nomenclature for cosmetic CIED 
implantation based on a combination of three components: 
incision for lead insertion, incision for generator insertion, and 
layer of generator implantation. In previous studies9)10) and 
Fig. 4. Chest radiography, posteroanterior (A) and left lateral (B) views after combined subpectoral implantation of an implantable cardioverter-defibrillator 
and augmentation mammoplasty.
A B
Fig. 5. Clinical photographs before (A) and after (B) the combined 
subpectoral implantable cardioverter-defibrillator implantation and 
augmentation mammoplasty procedure. Right breast volume increased 
from 45 to 163 mL and left breast volume from 56 to 169 mL. There is 
neither a visible scar nor protrusion on the chest. 
A B
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real-world practice, four types of cosmetic CIED implantation 
have been reported: axillary-axillary-subpectoral, axillary-
inframammary-submammary, infraclavicular-axillary-subpectoral, 
and infraclavicular-inframammary-submammary implantation (Fig. 
6). The submammary layer lies beneath the mammary glandular 
tissue and above the pectoralis major muscle. In the present 
case, we used axillary-axillary-subpectoral implantation. Axillary-
axillary-subpectoral implantation is superior at it results in minimal 
and invisible scarring. 
Complications of subpectoral or submammary CIED implantation 
are not higher than that of those implanted subcutaneously. 
Obeyesekere et al.10) reported 20 cases of submammary ICD 
implantation, and did not note complications related to the 
implantation site, such as infection and device migration. During a 
follow-up of 5 years, the incidence of appropriate and inappropriate 
shock due to the ICD was similar to that reported in other studies. 
Another study11) compared subcutaneous and submuscular 
approaches in patients with pectoral ICD. The overall risk of any 
pocket-related complications was not different between the two 
groups, and lead complications occurred more frequently in the 
subcutaneous group.11) Patients’ satisfaction and acceptance 
rates were higher in the submammary or subpectoral group than 
subcutaneous group.7)9) 
A generator is implanted between the pectoralis major muscle and 
the rib cage via an axillary incision. Although the device is implanted 
subpectorally or submammarily, esthetic concerns remain in female 
patients with low body weight and small breasts. A combined 
subpectoral ICD implantation and breast augmentation surgery has 
been reported.12) Breast augmentation helps conceal the remaining 
protuberant chest due to the device. A combined subpectoral 
CIED implantation and augmentation mammoplasty procedure 
is feasible, because the layer of CIED implantation is identical to 
that of breast implantation. Moreover, both can be implanted via 
the same axillary incision. This combined procedure is usually 
performed by cooperation between a cardiac electrophysiologist 
and a plastic surgeon under general anesthesia. In addition, pain 
control including patient-controlled analgesia is usually necessary 
after surgery. Therefore, multidisciplinary care by a cardiac 
electrophysiologist, a plastic surgeon, and an anesthesiologist is 
important for combined surgery. In particular, vital signs and heart 
function monitoring during the operation are essential in patients 
with heart failure. Generator change, ICD removal or repositioning 
from the subpectoral to subcutaneous area also requires general 
anesthesia. As mentioned above, the complication rates of CIED 
implantation in the subpectoral area and other areas are similar. 
Indeed, in some case series, subpectoral CIED implantations not 
combined with breast augmentation via an axillary approach were 
performed successfully.13) However, later procedures should be 
carefully managed, because the ICD generator and breast implant 
were implanted in the same subpectoral layer. 
Cases of combined subpectoral ICD implantation and 
augmentation mammoplasty in Asians have not been reported 
previously. Combined subpectoral ICD implantation and 
augmentation mammoplasty via the axillary incision is feasible in 
young female patients with ICD indications and small breasts. 
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